Latest financial market updates and expert analysis
Analysis The countdown to a potentially transformative data readout is on at Sellas Life Sciences. The biotech group’s Phase 3 REGAL trial, testing Galinpepimut-S in acute myeloid leukemia (AML), has recorded...
Amazon shares have entered a stormy patch, sliding roughly 14% from their early May peak as investors grapple with a...
The regulatory net tightening around global supply chains is forcing corporations into a compliance arms race, and for a small...
Two days before quarterly results, Micron unveiled a strategic partnership with Anthropic that sent its shares up 5.5 percent on...
Almonty Industries has spent months trading in the shadow of a drawn-out downtrend, but the past few weeks have rewritten...
The shares have shed more than 7% in a week, sliding another 3.4% on the latest session to €43.42. At...
The founders of Partners Group have been snapping up shares at a pace not seen in years — nearly 60...
SAP shares hit a fresh 52-week low on Monday, sliding to €130.62 before recovering slightly to €131.28 — a decline...
Rockstar Games has put a firm date on the table — June 25 — for Grand Theft Auto VI pre-orders,...
The vicious selloff in Nemetschek shares shows no sign of letting up. The stock struck a fresh 52-week low of...
The Strait of Hormuz is shut again, and the Middle East is simmering. Historically, that combination sends investors rushing for...
